MYND Life Sciences Announces LOI with Eyam Vaccines and Immunotherapeutics Post published:June 17, 2021 Post category:Press Release
atai Life Sciences Announces Pricing of Upsized Initial Public Offering Post published:June 17, 2021 Post category:Press Release
MINDCURE Develops Proprietary Ketamine-Enhanced Psychotherapy Protocols for Treatment of Pain and Depression Post published:June 17, 2021 Post category:Press Release
Entheon Biomedical Corp. Announces Agreement to Acquire Lobo Genetics Inc. Post published:June 16, 2021 Post category:Press Release
Creso Pharma and Red Light Holland Merge to Introduce The HighBrid Lab (TM), a Leading Global Psychedelics x Cannabis Company, Specializing in Recreational Products, Applied Science, Technology and Innovation Post published:June 16, 2021 Post category:Press Release
Mydecine Unveils Artificial Intelligence Drug Discovery Program Post published:June 16, 2021 Post category:Press Release
Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic Molecule CYB004 Post published:June 16, 2021 Post category:Press Release
Bright Minds Biosciences Announces Application to List on Nasdaq Post published:June 16, 2021 Post category:Press Release
Optimi Health Completes Pre-Clinical Trial Application Meeting Post published:June 15, 2021 Post category:Press Release
PharmaTher Files FDA Pre-IND Meeting Request and Briefing Package For KETABET⢠To Treat Depression Post published:June 15, 2021 Post category:Press Release